plasma levels of several closely related tricyclic antidepressants have been reported to be increased by the concomitant administration of methylphenidate or hepatic enzyme inhibitors (e.g., cimetidine, fluoxetine) and decreased by the concomitant administration of hepatic enzyme inducers (e.g., barbiturates, phenytoin), and such an effect may be anticipated with CMI as well.
<tricyclic antidepressants, mechanism, methylphenidate>, <tricyclic antidepressants, mechanism, cimetidine>, <tricyclic antidepressants, mechanism, fluoxetine>, <tricyclic antidepressants, mechanism, barbiturates>, <tricyclic antidepressants, mechanism, phenytoin>, <methylphenidate, mechanism, CMI>, <cimetidine, mechanism, CMI>, <fluoxetine, mechanism, CMI>, <barbiturates, mechanism, CMI>, <phenytoin, mechanism, CMI>